Chemotherapy for advanced gastric cancer: across the years for a standard of care

@article{Scartozzi2007ChemotherapyFA,
  title={Chemotherapy for advanced gastric cancer: across the years for a standard of care},
  author={M. Scartozzi and E. Galizia and L. Verdecchia and R. Berardi and S. Antognoli and S. Chiorrini and S. Cascinu},
  journal={Expert Opinion on Pharmacotherapy},
  year={2007},
  volume={8},
  pages={797 - 808}
}
Chemotherapy is of crucial importance in advanced gastric cancer patients, in order to obtain palliation of symptoms and improve survival. The most extensively studied drugs as single agents are 5-fluorouracil, cisplatin, doxorubicin, epirubicin, mitomycin C and etoposide. Newer chemotherapeutic agents include the taxanes (docetaxel and paclitaxel), oral fluoropyrimidines (capecitabine and S-1), oxaliplatin and irinotecan. Randomised trials comparing monotherapy with combination regimens have… Expand
46 Citations
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
  • 6
  • PDF
Phase II study of sunitinib as second-line treatment for advanced gastric cancer
  • 172
  • PDF
Factors predicting outcome for advanced gastroesophageal cancer in elderly patients receiving palliative chemotherapy.
  • 15
Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
  • 62
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 86 REFERENCES
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
  • G. Cocconi, M. Bella, +7 authors M. Soldani
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1994
  • 102
Palliative chemotherapy for advanced gastric cancer.
  • 163
Evolving chemotherapy for advanced gastric cancer.
  • 177
  • PDF
Phase II Study of Paclitaxel and Carboplatin in Patients With Advanced Gastric Cancer
  • 59
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
  • 318
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
  • D. Kelsen, O. Atiq, +7 authors M. Brennan
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1992
  • 281
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer.
  • 160
Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. Final results of a multicenter phase II trial.
  • E. Woell, T. Kuehr, +5 authors J. Thaler
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
  • 4
Doxifluridine as palliative treatment in advanced gastric and pancreatic cancer patients.
  • 15
...
1
2
3
4
5
...